Anagram Therapeutics, Inc. logo

Anagram Therapeutics, Inc. Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Anagram Therapeutics, Inc. is a clinical-stage biotechnology company based in Natick, Massachusetts. It concentrates on gastrointestinal diseases, applying proprietary enzyme technologies to address malabsorption and nutrient metabolism disorders, including conditions such as cystic fibrosis and other rare diseases. Its lead candidate, ANG003, targets malabsorption and exocrine pancreatic insufficiency and represents a broad-spectrum enzyme replacement approach. In addition to ANG003, the company seeks to advance a pipeline addressing how these disorders disrupt the body’s ability to process fats, sugars, proteins, vitamins, and other nutrients. In 2023, Anagram expanded its collaboration with ATUM to pursue orally delivered enzyme therapies for malabsorption and nutrient metabolism disorders. The organization operates within the biotechnology research sector and maintains a relatively small to mid-sized team.

Find Anagram Therapeutics, Inc. employees' phone numbers or email addresses

Anagram Therapeutics, Inc. Global Highlights

Location
Employees

North America
31

Minus sign iconPlus sign icon
  • United States Of America
    31

Anagram Therapeutics, Inc.'s Leadership

  • Chief Medical Officer at Anagram Therapeutics, Inc.
    E. B.
    Chief Medical Officer
  • Chief Operating Officer at Anagram Therapeutics, Inc.
    H. W.
    Chief Operating Officer
  • Chief Of Technology Development at Anagram Therapeutics, Inc.
    D. B.
    Chief Of Technology Development
  • Vp Clinical Strategic Operations at Anagram Therapeutics, Inc.
    M. W. C.
    Vp Clinical Strategic Operations
  • President And Chief Executive Officer at Anagram Therapeutics, Inc.
    R. G.
    President And Chief Executive Officer
  • Evp, General Counsel & Head Of Corporate Development at Anagram Therapeutics, Inc.
    J. C.
    Evp, General Counsel & Head Of Corporate Development
  • Executive Vice President, Regulatory Affairs at Anagram Therapeutics, Inc.
    P. N.
    Executive Vice President, Regulatory Affairs
  • Vice President, Finance at Anagram Therapeutics, Inc.
    T. C.
    Vice President, Finance

Anagram Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Sales
  • Quality Assurance
  • Biotechnology
  • Business
  • Legal
  • Other
  • Administrative
  • Program & Project Management

Contact profiles from Anagram Therapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • Chief Medical Officer at Anagram Therapeutics, Inc.
    E. B.
    Chief Medical Officer
    United States, Massachusetts
    May 19, 2026
  • President And Chief Executive Officer at Anagram Therapeutics, Inc.
    R. G.
    President And Chief Executive Officer
    United States, Massachusetts
    Mar 24, 2026
  • Chief Operating Officer at Anagram Therapeutics, Inc.
    H. W.
    Chief Operating Officer
    United States, Massachusetts
    Jun 01, 2026
  • Evp, General Counsel & Head Of Corporate Development at Anagram Therapeutics, Inc.
    J. C.
    Evp, General Counsel & Head Of Corporate Development
    United States, Massachusetts
    Jun 10, 2026
  • Chief Of Technology Development at Anagram Therapeutics, Inc.
    D. B.
    Chief Of Technology Development
    United States, Massachusetts
    May 15, 2026
  • Vp Clinical Strategic Operations at Anagram Therapeutics, Inc.
    M. W. C.
    Vp Clinical Strategic Operations
    United States
    Jun 01, 2026
  • Executive Vice President, Regulatory Affairs at Anagram Therapeutics, Inc.
    P. N.
    Executive Vice President, Regulatory Affairs
    United States, Massachusetts
    Jun 01, 2026
  • Vice President, Finance at Anagram Therapeutics, Inc.
    T. C.
    Vice President, Finance
    United States
    Apr 17, 2026
  • Director Operations, Program Management/Site Engagement at Anagram Therapeutics, Inc.
    S. R. P. M. C.
    Director Operations, Program Management/Site Engagement
    United States, New York
    Jun 10, 2026
  • Senior Director, Msat at Anagram Therapeutics, Inc.
    G. P.
    Senior Director, Msat
    United States
    May 19, 2026

Frequently Asked Questions

What is Anagram Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
Anagram Therapeutics, Inc. operates in the Biotechnology Research industry. Explore Anagram Therapeutics, Inc.'s company overview page for more information.

What is Anagram Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Anagram Therapeutics, Inc. employees' email format typically follows the pattern of FLast@anagramtx.com. Trying to find reliable and up-to-date employee contact data? Find more Anagram Therapeutics, Inc. email formats with LeadIQ.

How many employees does Anagram Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Anagram Therapeutics, Inc. has approximately 37 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are Anagram Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Anagram Therapeutics, Inc.'s key employees include:

  • Chief Medical Officer: E. B.
  • Chief Operating Officer: H. W.
  • Chief Of Technology Development: D. B.
  • Vp Clinical Strategic Operations: M. W. C.
  • President And Chief Executive Officer: R. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.